Growth Stocks To Watch Now - March 6th

Today, three significant growth stocks to keep an eye on are Blackstone, BlackRock, and Novo Nordisk A/S, as highlighted by MarketBeat's stock screener tool. Growth stocks are shares in companies that are predicted to expand their revenues and earnings at rates much higher than the market average. Investors often prefer these stocks for their potential capital gains, although these companies might reinvest their earnings instead of paying out dividends, which can contribute to greater volatility in stock prices.

Blackstone (BX)

Blackstone Inc. operates as an alternative asset management firm with a focus on real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity, as well as multi-asset class strategies. The firm is known for investing in early-stage companies and offering capital market services.

During mid-day trading on Thursday, Blackstone's stock (NYSE:BX) experienced a decrease of $5.69, bringing its price down to $146.35. The trading volume reached 2,365,439 shares, compared to an average volume of 3,270,524 shares. With a market capitalization of $105.67 billion, the company's price-to-earnings ratio stands at 40.30, and it has a PEG ratio of 1.07 alongside a beta of 1.55. The fifty-day moving average is $170.52, while the two-hundred-day moving average is $166.84. Notably, Blackstone has a debt-to-equity ratio of 0.61, a current ratio of 0.67, and a quick ratio of 0.71. Over the past year, the stock hit a low of $115.82 and a high of $200.96.

BlackRock (BLK)

BlackRock, Inc. is a publicly-owned investment management firm that primarily serves institutional, intermediary, and individual investors, including pension plans, insurance companies, mutual funds, public institutions, governments, and charities.

On Thursday, BlackRock stock traded down $12.88 to reach $955.26. The company saw a trading volume of 304,683 shares, while its average volume was 830,973 shares. BlackRock holds a market capitalization of $147.95 billion, with a PE ratio of 22.75 and a price-to-earnings growth ratio of 1.90. The current ratio and quick ratio are both 5.23, and the company has a debt-to-equity ratio of 0.45. The fifty-two week low for BlackRock is $745.55, while the high stands at $1,084.22.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S is involved in the research, development, manufacture, and distribution of pharmaceutical products across Europe, the Middle East, Africa, and North America, among other regions. This company operates in two segments: Diabetes and Obesity Care, and Rare Disease.

As of Thursday's mid-day trading, Novo Nordisk's stock fell by $2.97, bringing its price to $87.89. The volume for this stock was 3,157,884 shares compared to an average trading volume of 8,797,072 shares. Novo Nordisk has a market cap of $394.42 billion, a price-to-earnings ratio of 26.71, and a P/E/G ratio of 0.90, with a beta of 0.42. The stock's 12-month low is $77.82, and its high is $148.15. The fifty-day moving average is $84.91, and the two-hundred-day moving average is $105.74. The company’s current ratio is 0.74, the quick ratio is 0.55, and it has a debt-to-equity ratio of 0.62.

stocks, growth, investment